1 |
Swann K, Lai FA. The sperm phospholipase C-ζ and Ca2+ signalling at fertilization in mammals [J]. Biochem Soc Trans, 2016, 44(1): 267-272.
|
2 |
Machaty Z, Miller AR, Zhang L. Egg activation at fertilization[J]. Adv Exp Med Biol, 2017, 953: 1-47.
|
3 |
Sobinoff AP, Sutherland JM, Mclaughlin EA. Intracellular signalling during female gametogenesis[J]. Mol Hum Reprod, 2013, 19(5): 265-278.
|
4 |
Kimura Y, Yanagimachi R, Kuretake S, et al. Analysis of mouse oocyte activation suggests the involvement of sperm perinuclear material[J]. Biol Reprod, 1998, 58(6): 1407-1415.
|
5 |
Anifandis G, Messini C, Dafopoulos K, et al. Molecular and cellular mechanisms of sperm-oocyte interactions opinions relative to in vitro fertilization (IVF)[J]. Int J Mol Sci, 2014, 15(7): 12972-12997.
|
6 |
DeBaun MR, Niemitz EL, Feinberg AP. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19[J]. Am J Hum Genet, 2003, 72(1): 156-160.
|
7 |
Anifandis G, Messini CI, Dafopoulos K, et al. Sperm contributions to oocyte activation: more that meets the eye[J]. J Assist Reprod Genet, 2016, 33(3): 313-316.
|
8 |
Nomikos M, Yu Y, Elgmati K, et al. Phospholipase Cζ rescues failed oocyte activation in a prototype of male factor infertility [J]. Fertil Steril, 2013, 99(1): 76-85.
|
9 |
Sanusi R, Yu Y, Nomikos M, et al. Rescue of failed oocyte activation after ICSI in a mouse model of male factor infertility by recombinant phospholipase Cζ[J]. Mol Hum Reprod, 2015, 21(10): 783-791.
|
10 |
Simon L, Emery BR, Carrell DT. Review: diagnosis and impact of sperm DNA alterations in assisted reproduction[J]. Best Pract Res Clin Obstet Gynaecol, 2017, 44: 38-56.
|
11 |
Tavalaee M, Kiani-Esfahani A, Nasr-Esfahani MH. Relationship between phospholipase C-ζ, semen parameters, and chromatin status[J]. Syst Biol Reprod Med, 2017, 63(4): 259-268.
|
12 |
Tavalaee M, Kiani-Esfahani A, Nasr-Esfahani MH. Relationship between potential sperm factors involved in oocyte activation and sperm DNA fragmentation with intra-cytoplasmic sperm injection clinical outcomes[J]. Cell J, 2017, 18(4): 588-596.
|
13 |
Hoshi K, Yanagida K, Yazawa H, et al. Intracytoplasmic sperm injection using immobilized or motile human spermatozoon[J]. Fertil Steril, 1995, 63(6): 1241-1245.
|
14 |
Economou KA, Christopikou D, Tsorva E, et al. The combination of calcium ionophore A23187 and GM-CSF can safely salvage aged human unfertilized oocytes after ICSI[J]. J Assist Reprod Genet, 2017, 34(1): 33-41.
|
15 |
Murugesu S, Saso S, Jones BP, et al. Does the use of calcium ionophore during artificial oocyte activation demonstrate an effect on pregnancy rate? A meta-analysis[J]. Fertil Steril, 2017, 108(3): 468-482.e3.
|
16 |
Egashira A, Murakami M, Haigo K, et al. A successful pregnancy and live birth after intracytoplasmic sperm injection with globozoospermic sperm and electrical oocyte activation [J]. Fertil Steril, 2009, 92(6): 2037.e2035-2039.
|
17 |
Ozil JP. The parthenogenetic development of rabbit oocytes after repetitive pulsatile electrical stimulation[J]. Development, 1990, 109(1): 117-127.
|
18 |
Mansour R, Fahmy I, Tawab NA, et al. Electrical activation of oocytes after intracytoplasmic sperm injection: a controlled randomized study[J]. Fertil Steril, 2009, 91(1): 133-139.
|
19 |
Swann K, Ozil JP. Dynamics of the calcium signal that triggers mammalian egg activation[J]. Int Rev Cytol, 1994, 152: 183-222.
|
20 |
Zhang D, Pan L, Yang LH, et al. Strontium promotes calcium oscillations in mouse meiotic oocytes and early embryos through InsP3 receptors, and requires activation of phospholipase and the synergistic action of InsP3[J]. Hum Reprod, 2005, 20(11): 3053-3061.
|
21 |
Liu Y, Han XJ, Liu MH, et al. Three-day-old human unfertilized oocytes after in vitro fertilization/intracytoplasmic sperm injection can be activated by calcium ionophore a23187 or strontium chloride and develop to blastocysts[J]. Cell Reprogram, 2014, 16(4): 276-280.
|
22 |
Chen J, Qian Y, Tan Y, et al. Successful pregnancy following oocyte activation by strontium in normozoospermic patients of unexplained infertility with fertilisation failures during previous intracytoplasmic sperm injection treatment [J]. Reprod Fertil Dev, 2010, 22(5): 852-855.
|
23 |
Kim JW, Choi JL, Yang SH, et al. Live birth after SrCl(2) oocyte activation in previous repeated failed or low fertilization rates after ICSI of frozen-thawed testicular spermatozoa: case report[J]. J Assist Reprod Genet, 2012, 29(12): 1393-1396.
|
24 |
Vanden Meerschaut F, Nikiforaki D, Heindryckx B, et al. Assisted oocyte activation following ICSI fertilization failure[J]. Reprod Biomed Online, 2014, 28(5): 560-571.
|
25 |
Ebner T, Köster M, Shebl O, et al. Application of a ready-to-use calcium ionophore increases rates of fertilization and pregnancy in severe male factor infertility[J]. Fertil Steril, 2012, 98(6): 1432-1437.
|
26 |
Zhang Z, Wang T, Hao Y, et al. Effects of trehalose vitrification and artificial oocyte activation on the development competence of human immature oocytes[J]. Cryobiology, 2017, 74: 43-49.
|
27 |
Mizuta S, Takahashi C, Nishiyama R, et al. Clinical outcomes of artificial oocyte activation with calcium ionophore in intracytoplasmic sperm injection (ICSI) using testicular spermatozoa on sibling oocytes [J]. Hum Reprod, 2015, 30: 171.
|
28 |
Karabulut S, Aksünger Ö, Ata C, et al. Artificial oocyte activation with calcium ionophore for frozen sperm cycles[J]. Syst Biol Reprod Med, 2018, 64(5): 381-388.
|
29 |
Aydinuraz B, Dirican EK, Olgan S, et al. Artificial oocyte activation after intracytoplasmic morphologically selected sperm injection: a prospective randomized sibling oocyte study[J]. Hum Fertil (Camb), 2016, 19(4): 282-288.
|
30 |
Kang HJ, Lee SH, Park YS, et al. Artificial oocyte activation in intracytoplasmic sperm injection cycles using testicular sperm in human in vitro fertilization[J]. Clin Exp Reprod Med, 2015, 42(2): 45-50.
|
31 |
Heytens E, Parrington J, Coward K, et al. Reduced amounts and abnormal forms of phospholipase C ζ (PLCζ) in spermatozoa from infertile men[J]. Hum Reprod, 2009, 24(10): 2417-2428.
|
32 |
Vanden Meerschaut F, Leybaert L, Nikiforaki D, et al. Diagnostic and prognostic value of calcium oscillatory pattern analysis for patients with ICSI fertilization failure[J]. Hum Reprod, 2013, 28(1): 87-98.
|
33 |
Anifandis G, Messini CI, Dafopoulos K, et al. Genes and conditions controlling mammalian pre-and post-implantation embryo development[J]. Curr Genomics, 2015, 16(1): 32-46.
|
34 |
Miller N, Biron-Shental T, Sukenik-Halevy R, et al. Oocyte activation by calcium ionophore and congenital birth defects: a retrospective cohort study[J]. Fertil Steril, 2016, 106(3): 590-596.e2.
|
35 |
Capalbo A, Ottolini CS, Griffin DK, et al. Artificial oocyte activation with calcium ionophore does not cause a widespread increase in chromosome segregation errors in the second meiotic division of the oocyte [J]. Fertil Steril, 2016, 105(3): 807-814.e802.
|
36 |
Kobayashi R, Watanabe C, Ohgaki A, et al. Follow-up study of babies born from ART with oocyte activation using calcium ionophore [J]. Fertil Steril, 2015, 104(3): e299.
|
37 |
Vanden Meerschaut F, D'Haeseleer E, Gysels H, et al. Neonatal and neurodevelopmental outcome of children aged 3-10 years born following assisted oocyte activation[J]. Reprod Biomed Online, 2014, 28(1): 54-63.
|
38 |
Li B, Zhou Y, Yan Z, et al. Pregnancy and neonatal outcomes of artificial oocyte activation in patients undergoing frozen-thawed embryo transfer: a 6-year population-based retrospective study[J]. Arch Gynecol Obstet, 2019, 300(4): 1083-1092.
|
39 |
Takisawa T, Sato Y, Tasaka A, et al. Effect of oocyte activation by calcium ionophore A23187 or strontium chloride in patients with low fertilization rates and follow-up of babies [J]. Fertil Steril, 2011, 96(): S162.
|
40 |
Simopoulou M, Sfakianoudis K, Rapani A, et al. Considerations regarding embryo culture conditions: from media to epigenetics[J]. In Vivo, 2018, 32(3): 451-460.
|
41 |
Silveira PP, Portella AK, Goldani MZ, et al. Developmental origins of health and disease (DOHaD) [J]. J Pediatr (Rio J), 2007, 83(6): 494-504.
|